Nivolumab,ipilimumab,Cabozantinib
BMS
['rcc,(-irccs),(-srcc),(-urcc)']
the one and only , #rcc with variant histology expert presented the #cani trial!
awaiting more results! #asco23 
Senior Executive & Chief GU Cancers @DanaFarber; Prof Medicine @HarvardMed; 2021 Giants of Cancer Award ⚽ lover; 🚲@PanMass, seen on @msnbc @cnn @TODAYshow